key: cord-0426657-35jv3em8 authors: Rizvi, Zaigham Abbas; Babele, Prabhakar; Sadhu, Srikanth; Madan, Upasna; Tripathy, Manas Ranjan; Goswami, Sandeep; Mani, Shailendra; Kumar, Sachin; Awasthi, Amit; Dikshit, Madhu title: Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis date: 2022-05-17 journal: bioRxiv DOI: 10.1101/2022.05.16.492112 sha: 47dc285f16d237aacadb552f5fb09144f7eea616 doc_id: 426657 cord_uid: 35jv3em8 Severe coronavirus disease (COVID-19) is accompanied with acute respiratory distress syndrome & pulmonary pathology, and is presented mostly with inflammatory cytokine release, dysregulated immune response, skewed neutrophil/ lymphocyte ratio, and hypercoagulable state. Though vaccinations have proved effective in reducing the COVID-19 related mortality, the limitation of use of vaccine against immunocompromised, comorbidity, and emerging variants remains a concern. In the current study we investigate for the first-time the efficacy of Glycyrrhiza glabra (GG) extract, a potent immunomodulator, against SARS-CoV-2 infection in hamsters. Prophylactic treatment with GG showed protection against loss in body weight and 35-40% decrease in lung viral load along with reduced lung pathology in the hamster model. Remarkably, GG reduced the mRNA expression of pro-inflammatory cytokines and Plasminogen activator inhibito-1 (PAI-1). In-vitro, GG acted as potent immunomodulator by reducing Th2 and Th17 differentiation and IL-4 and IL-17A cytokine production. In addition, GG also showed robust potential to suppress ROS, mtROS and NETs generation in a concentration dependent manner in both human polymorphonuclear neutrophils (PMNs) and murine bone marrow derived neutrophils (BMDNs). Taken together, we provide evidence for the protective efficacy of GG against COVID-19 and its putative mechanistic insight, which might be developed as a future immunomodulatory approach against various pathologies with high cytokine production, aberrant neutrophil activation including coronavirus infection. Phone: +91-129-287-6482, fax: +91-129-287-6500 36 Introduction 6 and TNFα and their modulation by GG using commercial ELISA kits (Fig. 4SA & 4SB ). An 285 increase in the production of IL-6 and TNFα were observed when cells were primed with 286 TRLM before treatment with the inducers; IL-6 (52% in PMA and 78% in A23187) and TNFα 287 (96% in PMA and 45% in A23187. GG (100 μg/ml) exerted a profound inhibitory effect on the 288 release of IL-6 and TNFα from neutrophils when treated with either TRLM-PMA or TRLM-289 A23187. In particular, IL-6 and TNFα levels were reduced to 33% and 37% (p<0.05), 290 respectively when exposed to TRLM-A23187, whereas TRLM-PMA treatment resulted in a 291 decrease of 15-20% in both the cytokines. 292 Because phagocytosis is one of the important functions of neutrophils to evade any foreign 293 pathogen, we next examined the effect of GG, if any on this property of the neutrophils. 294 Human PMNs pretreated with GG for 60 min followed by PE-labelled latex beads (1 µm) 295 exhibited a modest reduction (14% (p<0.05)) in the phagocytosis only at the highest 296 concentration (300 µg/ml, Fig. S4C) , while 1-100 µg/ml of GG did not cause any noticeable 297 change. Further, since GG treatment showed mild inhibitory effect on phagocytosis we 298 subsequently assessed its effect on the bactericidal activity. Incubation of overnight grown 299 kanamycin-resistant E. coli with neutrophils resulted in the reduction of colonies from 7.9 x 300 10 8 to 2.4 x 10 8 CFU/ml (70% reduction, p<0.05, Fig. S4D & S4E) . Pre-treatment of human 301 peripheral neutrophils with 300 µg/ml GG did not impart any significant effect on the killing 302 activities of phagocytes; approximately 50% reduction in E. coli growth was observed when 303 bacteria were incubated with GG treated PMNs. However, a notable reduction in bacterial 304 growth of 17% (p<0.05) was observed at 300 µg/ml GG, suggesting a direct anti-microbial 305 effect of GG on microbial growth (Fig. S4D & S4E) . 306 Prophylactic use of GG ameliorates COVID-19 pathology in hamster. In summary, we 307 report that the prophylactic use of GG in SARS-CoV-2 infected hamsters helps in mitigating 308 the COVID-19 pathology. The effect of GG against COVID-19 could be through its potent immunomodulatory potential, inhibitory effects on NETosis and suppression of ROS 310 generation as illustrated in the summary figure (Fig. 7) . 311 Recent emergence of SARS-CoV-2 has caused unprecedented mortality which led to 314 development and emergency usage of COVID-19 vaccines (https://covid19.who.int/). Though 315 active vaccination against SARS-CoV-2 has been a largely successful strategy, emerging 316 variants such as Delta (B.1.617.2) and Omicron variant (B.1.1.516) of SARS-CoV-2 have 317 largely been able to escape the immune response elicited by the vaccination (42, 43) . This is 318 because of the mutations in the spike/ RBD regions of the variants which were used as an 319 immunogen for several vaccine candidates. Therapeutic use of anti-viral drugs such as 320 Remdesivir (a Rdrp prodrug inhibitor) or Favipiravir ( Corroborating the previously published computational results we found that GG when given 343 as prophylactic regime to hamsters results in substantially reduced gross pathology with 344 significant protection in body weight loss. Moreover, GG group also showed reduction in the 345 lung viral load as compared to the infected group however as compared to the remdesivir group 346 the inhibition by GG was lesser by 10-15%. Protection in the gross clinical parameters of GG 347 administered animals prompted us to look at the pathophysiology of lung as COVID-19 clinical 348 cases are characterized by lung injury and pneumonitis. Remarkably, the histological 349 parameters of GG lungs showed alleviation of lung pathology with overall reduced lung injury 350 score and lowered expression of lung injury markers. These results suggested as that 351 prophylactic treatment of GG is beneficial against COVID-19 in hamster which involves 352 resolving of the pulmonary pathology. 353 Previously published literature on GG or its components have shown robust 354 immunomodulatory effects of GG. For example, licorice which is a constituent of GG was able 355 to suppress LPS-induced NLRP3 inflammasomes and NF-kB activation (47) . This would mean 356 that GG could lower the inflammatory response induced by LPS. When the mechanism of this 357 inhibition was investigated, it was found that licorice inhibits COX-2 expression and in turn 358 reduces the prostaglandin (PGE2) levels (28,47). Another study have documented that 359 glycyrrhizin, another component of GG, reduces ROS generation by neutrophils thereby 360 suppressing tissue inflammation (27,48). These studies prompted us also to investigate the 361 immunomodulatory potential of GG. When spenocytes mRNA expression was studied for cytokines, we found that GG remarkably inhibited pro-inflammatory cytokines in a way which 363 was comparable to remdesivir, a prototype of anti-viral drug. Higher levels of cytokines such 364 as TNFα, IL17 in the early stages of infection have been linked with worsening of the disease 365 and tissue injury. Remarkably, GG was able to suppress the expression of all these 3 cytokines 366 at the peak of infection in hamster (ie 4dpi). In addition, GG also suppressed the expression of 367 T-bet which is a key transcription factor for Th1 response. This was an interesting finding, 368 corroborating the immunomodulatory potential of GG previously shown in the context of other 369 pathogenic infection, as it proved that the protective effect of GG against COVID-19 involves 370 in parts both anti-viral activity as well as immunomodulatory potential resulting in anti-371 inflammatory response. 372 CD4+ T helper cells are crucial components of adoptive immunity which coordinates in 373 providing immunity against pathogenic infection. On the other hand, it has been also shown 374 that dysregulated effector and regulatory T helper cell response leads to tissue injury and 375 worsening of the disease which is also seen in the case of COVID-19 (37,49). To further 376 validate the anti-inflammatory potential of GG and to evaluate GG effect on suppression of 377 effector T cells, we performed T cell differentiation assay in-vitro in presence or absence of 378 GG. Our results show that GG could inhibit the differentiation of Th1, Th2 and Th17 379 differentiation in a dose dependent manner much like the dexamethasone, a known 380 immunosuppressant (29). Interestingly, the lowest ID50 for in-vitro assay was found to be for 381 Th1 differentiation suggesting that GG at lower doses inhibits Th1 differentiation dramatically. 382 Since GG was also found to significantly inhibit thrombosis marker PAI-1, and during COVID-383 19 induction of thrombosis is strongly correlated with the neutrophils induced NETosis, we 384 investigated further if GG could modulate the neutrophil response and affect ROS generation. HGPRT GATAGATCCACTCCCATAACTG TACCTTCAACAATCAAGACATTC tryptase β2 TCGCCACTGTATCCCCTGAA CTAGGCACCCTTGACTTTGC chymase ATGAACCACCCTCGGACACT AGAAGGGGGCTTTGCATTCC muc1 CGGAAGAACTATGGGCAGCT GCCACTACTGGGTTGGTGTAAG Sftpd TGAGCATGACAGACGTGGAC GGCTTAGAACTCGCAGACGA Eotaxin ATGTGCTCTCAGGTCATCGC TCCTCAGTTGTCCCCATCCT PAI-1 CCGTGGAACCAGAACGAGAT ACCAGAATGAGGCGTGTCAG IFNγ TGTTGCTCTGCCTCACTCAGG AAGACGAGGTCCCCTCCATTC TNFα AGAATCCGGGCAGGTCTACT TATCCCGGCAGCTTGTGTTT IL13 AAATGGCGGGTTCTGTGC AATATCCTCTGGGTCTTGTAGATGG IL17A ATGTCCAAACACTGAGGCCAA GCGAAGTGGATCTGTTGAGGT IL10 GGTTGCCAAACCTTATCAGAA ATG TTCACCTGTTCCACAGCCTTG IL6 GGACAATGACTATGTGTTGTTAGAA AGGCAAATTTCCCAATTGTATCCAG 529 Fixed lung samples were embedded in paraffin blocks and sectioned into 3 µm sections 531 mounted on silane-coated glass slides. The sectioned slides were then used for staining with 532 hematoxylin and eosin dye as previously described (76). Each stained sample were then 533 analyzed and captured at 10X magnification. Assessment for the histological score was carried 534 out through blind scoring for each sample by a professional histologist on a scale of 0-5 (where 535 0 indicated absence of histological feature while 5 indicated highest score). Disease index score 536 was calculated by addition of all the individual histological scores. 537 nodes of 6-8 weeks old C57BL/6 mice. The cells were activated using soluble anti-CD3 539 (2ug/ml) and differentiated into Th1 conditions by adding recombinant mouse IL-12 (15ng/ml) 540 cytokine or Th2 conditions by adding recombinant mouse IL-4 (15ng/ml) cytokine or Th17 541 conditions by adding TGF-beta (2ng/ml) plus IL-6 cytokine (25ng/ml) (78,79). Glycyrrhiza 542 gabra was added in concentrations ranging from 10ug/ml to 1000ug/ml at the start of culture. and data was analysed with FlowJo software. 553 wild-type male mice (20-25 g, 12-16 weeks) using the method described previously (71). Long 556 bones were flushed with HBSS + 0.1% BSA through a sterile tube followed by centrifugation 557 at 400 x g for 10 min at 10 o C. Pellet were resuspended in 45% Percoll and gently layered over 558 Percoll density gradient (81%-62%-55%). After centrifugation at 1700 x g for 30 min with 559 acceleration 5 m/s 2 and deceleration 4 m/s 2 , band between 81% and 62% were harvested and 560 assessed for their viability by Trypan blue and purity by anti-Ly6G and anti-CD11b antibodies. 561 Human neutrophils were isolated from the peripheral blood obtained from a healthy donor, by 562 following Percoll density gradient method as described earlier (80). Briefly, 2 ml buffy coat 563 were incubated with 6% dextran at 37 o C for 30 min. The upper phase was collected and 564 centrifuged at 1800 x g for 10 min. Pellet was mixed in HBSS containing 0.1% BSA and 565 layered on top of the Percoll gradient (81%-62%) before centrifuging at 1800 x g for 30 min. (1:200, anti-mice AF488 and anti-rabbit AF594) using the confocal microscope (Olympus 598 FV3000) at 100X resolution. DNA was stained with DAPI (0.5 μg/ml). 599 The levels of IL6 and TNFα in the supernatant/cell-free samples after the centrifugation were 601 measured by using the monoclonal antibody-based mouse interleukin ELISA kits. Briefly 100 602 μl of media from cells (1.0 x 10 6 cells/ml) treated with TRLM and PMA/A23187, following pre-incubation with GG/vehicle, was used to measure the cytokines referring the 604 manufacturer's instruction. 605 To assess the phagocytosis, PE-labelled latex beads were incubated with GG pre-treated human 607 PMNs (1.0 x 10 4 ) at 1:50 (neutrophil: beads) ratio and were analyzed using FACS (75) after 608 quenching the extracellular fluorescent signal of adherent beads with Trypan blue (0.4%). In a 609 separate experiment, GG pre-exposed human neutrophils were treated with kanamycin- The authors declare no conflict of interest. 638 The authors declare no competing interest. 640 GG showed a marked inhibitory effect on A23187-induced cytokines secretion. *p<0.05, 726 **p<0.01, vs respective control groups; #p<0.05, ##p<0.01 vs PMA/A23187 treated groups. 727 All the data are represented as Mean ± SEM, n = min 3 per group, and statistical analysis 728 consisted of one-way ANOVA followed by Bonferroni's test. C, control; GG100, 100 μg/ml; 729 GG300, 300 μg/ml; T, TRLM; P, PMA; A, A23187. 730 Th17 GG 10μg/ml GG 50μg/ml GG 100μg/ml GG 300μg/ml GG 500μg/ml GG 750μg/ml Th0 IL-4 CD4 Th2 GG 10μg/ml GG 100μg/ml GG 300μg/ml GG 500μg/ml GG 750μg/ml GG 1mg/ml GG 50μg/ml Th0 CD4 IFNγ Th1 GG 10μg/ml GG 50μg/ml GG 100μg/ml GG 300μg/ml GG 500μg/ml Th0 SARS-CoV-2: virus dynamics and host response Clinical Characteristics of Coronavirus Disease 2019 in China Cytokine release syndrome in severe COVID-19 Lymphopenia 761 predicts disease severity of COVID-19: a descriptive and predictive study COVID-19 and cardiovascular disease: 764 from basic mechanisms to clinical perspectives Implications of gastrointestinal manifestations of COVID-19 COVID-770 19-associated gastrointestinal and liver injury: clinical features and potential 771 mechanisms Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Neutrophil-777 to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in 778 the early stage The emerging role of neutrophil extracellular traps in severe acute respiratory 783 syndrome coronavirus 2 (COVID-19) NETosis and Neutrophil Extracellular Traps in COVID-19: 786 Immunothrombosis and Beyond SARS-CoV-2-triggered neutrophil 791 extracellular traps mediate COVID-19 pathologySARS-CoV-2 directly triggers ACE-792 dependent NETs The Emerging Role of NETs in Venous 795 Thrombosis and Immunothrombosis A systematic review of SARS-CoV-2 799 vaccine candidates 802 Identification of natural compounds with antiviral activities against SARS-associated 803 coronavirus Remdesivir for the Treatment of Covid-19 -Final 806 Report Favipiravir at high doses has potent antiviral 810 activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity Identification of existing pharmaceuticals and herbal medicines as 814 inhibitors of SARS-CoV-2 infection Edible 816 and Herbal Plants for the Prevention and Management of COVID-19 Search of Herbal Anti-SARS-Cov2 Dietary therapy and herbal medicine for COVID-19 821 prevention: A review and perspective In silico screening of Chinese herbal medicines 824 with the potential to directly inhibit 2019 novel coronavirus Identification of existing pharmaceuticals and herbal medicines as 828 inhibitors of SARS-CoV-2 infection Golden Syrian hamster as a model to study 831 cardiovascular complications associated with SARS-CoV-2 infection. eLife (2022) Simulation of the Clinical and Pathological Manifestations Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications 836 for Disease Pathogenesis and Transmissibility Pathogenesis and transmission of SARS-CoV-2 in golden 840 hamsters Effects of Glycyrrhiza glabra polysaccharides 842 on immune and antioxidant activities in high-fat mice The immunomodulatory activities of licorice 845 polysaccharides (Glycyrrhiza uralensis Fisch.) in CT 26 tumor-bearing mice Dexamethasone in Hospitalized Patients with Covid-19 Proposing 850 high-affinity inhibitors from Glycyrrhiza glabra L. against SARS-CoV-2 infection: virtual 851 screening and computational analysis AlKehayez 854 NM, Wabaidur SM, Shakya A. Identification of bioactive compounds from Glycyrrhiza 855 glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural 856 protein-15: a pharmacoinformatics study Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 859 Infection? Effects of Licorice on clinical symptoms and laboratory signs in 862 moderately ill patients with pneumonia from COVID-19: A structured summary of a 863 study protocol for a randomized controlled trial 866 Dysregulation of immune response in patients with COVID-19 in Wuhan Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection 870 Explains Severe Outcomes in COVID-19 The trinity of COVID-19: immunity, 874 inflammation and intervention COVID-19 infection: the perspectives on immune responses Effect of Prophylactic Use of Intranasal Oil Formulations in the 881 Hamster Model of COVID-19 COVID-19 immune signatures 886 reveal stable antiviral T cell function despite declining humoral responses Neutrophil extracellular traps infiltrate the lung 890 airway, interstitial, and vascular compartments in severe COVID-19 NET balancing: a problem in inflammatory lung diseases SARS-CoV-2 B.1.617.2 Delta variant replication and immune 898 evasion Structural basis of SARS-CoV-2 Omicron immune 901 evasion and receptor engagement Gomaa AA, Abdel-Wadood YA. The potential of glycyrrhizin and licorice extract in 906 combating COVID-19 and associated conditions Impact of Different Treatment Modalities on Immunity Against 909 COVID-19 Free radical-scavenging, antioxidant and 913 immunostimulating effects of a licorice infusion (Glycyrrhiza glabra L.) The effect of glycyrrhizin on maturation and T 916 cell stimulating activity of dendritic cells T cell responses in patients with COVID-19 The TLR7/8 Agonist CL097 Primes N-Formyl-Methionyl-Leucyl-922 Phenylalanine-Stimulated NADPH Oxidase Activation in Human Neutrophils: Critical 923 Role of p47phox Phosphorylation and the Proline Isomerase Pin1 Selective and direct activation of human neutrophils but not eosinophils by Toll-like 927 receptor 8 Toll-like receptors stimulate human neutrophil 930 function TLR9 Activation Induces Normal Neutrophil 933 Responses in a Child with IRAK-4 Deficiency: Involvement of the Direct PI3K Pathway Inhibition 936 of Neutrophil Apoptosis by TLR Agonists in Whole Blood: Involvement of the 937 Phosphoinositide 3-Kinase/Akt and NF-κB Signaling Pathways, Leading to Increased 938 Levels of Mcl-1, A1, and Phosphorylated Bad Expression and Function of Toll-Like Receptors in Eosinophils: 942 Activation by Toll-Like Receptor 7 Ligand Barthwal 945 MK, Dikshit M. Oxidized LDL induced extracellular trap formation in human neutrophils 946 via TLR-PKC-IRAK-MAPK and NADPH-oxidase activation. Free Radical Biology and 947 Medicine Eugenia aurata and Eugenia punicifolia HBK 950 inhibit inflammatory response by reducing neutrophil adhesion, degranulation and NET 951 release Polypharmacological Profiles Underlying the Antitumor Property of Salvia miltiorrhiza 955 Root (Danshen) Interfering with NOX-Dependent Neutrophil Extracellular Traps Metabolic Insight of Neutrophils in Health and Disease Myeloperoxidase associated with 962 neutrophil extracellular traps is active and mediates bacterial killing in the presence of 963 hydrogen peroxide SK3 channel and mitochondrial ROS 965 mediate NADPH oxidase-independent NETosis induced by calcium influx NETosis: Molecular Mechanisms, Role in Physiology and 969 Pathology EPR detection of cellular and 972 mitochondrial superoxide using cyclic hydroxylamines Targeting mitochondrial oxidative stress with MitoQ 976 reduces NET formation and kidney disease in lupus-prone MRL-lpr mice Chromatin remodelling and autocrine TNFα are 980 required for optimal interleukin-6 expression in activated human neutrophils The IRAK-983 ERK-p67phox-Nox-2 axis mediates TLR4, 2-induced ROS production for IL-1β 984 transcription and processing in monocytes The inflammasomes Thioredoxin-interacting protein links 989 oxidative stress to inflammasome activation Inflammasomes: mechanism of action, role in disease, 992 and therapeutics NLRP3 Inflammasome Assembly in Neutrophils Is Supported by 995 PAD4 and Promotes NETosis Under Sterile Conditions L-Arginine 999 and tetrahydrobiopterin supported nitric oxide production is crucial for the 1000 microbicidal activity of neutrophils Immunomodulatory activities of 1003 the ethanolic extract of Caesalpinia bonducella seeds Immunostimolatory activities of Vigna mungo L. extract in male 1006 Controls Phagocyte Bactericidal Activity by Sensing and Regulating ROS Interaction of Inducible Nitric Oxide Synthase with Rac2 Regulates 1014 Reactive Oxygen and Nitrogen Species Generation in the Human Neutrophil 1015 Phagosomes: Implication in Microbial Killing Evidence of CD1d pathway of lipid antigen presentation in 1018 mouse primary lung epithelial cells and its up-regulation upon Mycobacterium bovis 1019 BCG infection High-salt diet mediates interplay between NK cells and gut microbiota to 1022 induce potent tumor immunity EGFR-HIF1α signaling positively regulates the differentiation of IL-9 producing T helper 1026 cells Transcription factor Foxo1 is essential for IL-9 induction in T 1029 helper cells Glutathionylation of p47phox sustains superoxide generation in activated neutrophils High oxidative stress adversely affects NFκB mediated induction of 1036 inducible nitric oxide synthase in human neutrophils: Implications in chronic myeloid 1037 leukemia